Physician profile
Dwight A Silvera
NPI 1376553487
$28,064.13
in general payments reported to CMS, 2019-2025
31 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,213 · 2020: $3,628 · 2021: $1,402 · 2022: $664 · 2023: $953 · 2024: $4,874 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $16K · Food and Beverage: $2,121 · Travel and Lodging: $599 · Long Term Medical Supply Or Device Loan: $514 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $15,825.00 |
| Food and Beverage | $2,121.49 |
| Travel and Lodging | $599.18 |
| Long Term Medical Supply Or Device Loan | $513.52 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $17,039.72 | 2023-2025 | Purified Cortrophin Gel, Iluvien, Yutiq |
| Johnson & Johnson Surgical Vision, INC. | $5,484.02 | 2019-2021 | |
| Alcon Vision LLC | $901.70 | 2019-2025 | Clareon, Clareon Panoptix Pro, Acrysof Iq Panoptix Uv Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $646.11 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $616.57 | 2021-2024 | Lumera 700 |
| Bausch & Lomb Americas INC. | $572.60 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Glaukos Corporation | $399.08 | 2019-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished), Idosetr |
| Mallinckrodt Hospital Products INC. | $394.68 | 2021-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $382.25 | 2019-2023 | |
| Shire North American Group INC | $346.78 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $250.18 | 2020-2024 | Eylea Hd, Eylea |
| Sun Pharmaceutical Industries INC. | $212.22 | 2019-2022 | |
| Allergan, INC. | $114.97 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $82.40 | 2019 | |
| Amgen INC. | $69.87 | 2024-2025 | Tepezza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $68.64 | 2022 | |
| Oyster Point Pharma, INC. | $68.09 | 2022-2023 | Tyrvaya |
| New World Medical,INC. | $57.98 | 2021-2025 | Streamline, Clearpath, Kahook Dual Blade |
| Eyepoint US, INC. | $45.44 | 2022-2023 | |
| Dompe US, INC. | $42.41 | 2025 | Oxervate |
| Apellis Pharmaceuticals, INC. | $40.51 | 2022-2023 | Syfovre |
| Aerie Pharmaceuticals, INC. | $33.33 | 2019-2021 | |
| Biotissue Holdings INC. | $31.87 | 2019-2025 | |
| Kala Pharmaceuticals, INC. | $28.39 | 2019 | |
| Recordati_rare_diseases_inc. | $25.34 | 2023 | Cystadrops |
| Sight Sciences, INC. | $24.86 | 2021-2023 | Omni Surgical System |
| Astellas Pharma US INC | $21.45 | 2025 | Izervay |
| Sandoz INC. | $20.76 | 2024 | Cimerli |
| Horizon Therapeutics Plc | $16.86 | 2023 | Tepezza |
| Harrow Eye, LLC | $15.45 | 2025 | Triesence |
| Quidel Corporation | $9.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Silvera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.